These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3562900)

  • 1. Different peripheral and central antagonistic activity of new glutaramic acid derivatives on satiety induced by cholecystokinin in rats.
    Makovec F; Bani M; Chistè R; Revel L; Rovati LC; Setnikar I
    Regul Pept; 1986 Dec; 16(3-4):281-90. PubMed ID: 3562900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proglumide has access to brain and antagonizes the central satiety effect of cholecystokinin octapeptide in the dog.
    Inui A; Inoue T; Sakatani N; Oya M; Morioka H; Baba S
    Brain Res; 1987 Aug; 417(2):355-9. PubMed ID: 3651819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of cholecystokinin antagonists on satiety induced by cholecystokinin octapeptide in dogs].
    Sakatani N; Inui A; Baba S
    Nihon Naibunpi Gakkai Zasshi; 1989 Oct; 65(10):1149-58. PubMed ID: 2591604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of central and peripheral cholecystokinin receptors by new glutaramic acid derivatives with cholecystokinin-antagonistic activity.
    Makovec F; Bani M; Chisté R; Revel L; Rovati LC; Rovati LA
    Arzneimittelforschung; 1986; 36(1):98-102. PubMed ID: 3006713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CR-1409: a potent inhibitor of cholecystokinin-stimulated amylase release and cholecystokinin binding in rat pancreatic acini.
    Iwamoto Y; Yamamoto R; Kuzuya T
    Pancreas; 1987; 2(1):85-90. PubMed ID: 2437574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of CR 1409, a potent CCK receptor antagonist, on basal and stimulated pancreatic secretion in rat.
    Takács T; Nagy I; Pap A; Varró V
    Pancreas; 1990; 5(1):60-4. PubMed ID: 2293712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral factors in the mediation of cholecystokinin-induced satiety as assessed by comparative potencies of cholecystokinin antagonists.
    Murphy RB; Smith GP; Schneider LH; Gibbs J
    Peptides; 1992; 13(1):77-81. PubMed ID: 1620660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of proglumide on cholecystokinin-, bombesin-, and glucagon-induced satiety in the rat.
    Collins S; Walker D; Forsyth P; Belbeck L
    Life Sci; 1983 May; 32(19):2223-9. PubMed ID: 6843294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking of cholecystokinin octapeptide behavioral effects by proglumide.
    Katsuura G; Hsiao S; Itoh S
    Peptides; 1984; 5(3):529-34. PubMed ID: 6089145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-CCK effect of glutaramic acid derivatives in anesthetized and conscious rats.
    Takács T; Nagy I; Pap A; Varró V
    Pancreas; 1988; 3(4):465-70. PubMed ID: 3174609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loxiglumide. A new proglumide analog with potent cholecystokinin antagonistic activity in the rat pancreas.
    Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
    Dig Dis Sci; 1989 Jun; 34(6):857-64. PubMed ID: 2470557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central and peripheral proglumide administration and cholecystokinin-induced satiety.
    Willis GL; Hansky J; Smith GC
    Regul Pept; 1986 Aug; 15(1):87-98. PubMed ID: 3532220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New proglumide-analogue CCK receptor antagonists: very potent and selective for peripheral tissues.
    Niederau C; Niederau M; Williams JA; Grendell JH
    Am J Physiol; 1986 Jun; 250(6 Pt 1):G856-60. PubMed ID: 2424321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inhibitory effect of CR 1409 (cholecystokinin antagonist) on pancreatic exocrine secretion in rats].
    Shiratori K; Watanabe S; Shimizu K; Moriyoshi Y; Chang JH; Takeuchi T
    Nihon Shokakibyo Gakkai Zasshi; 1989 Jan; 86(1):70-6. PubMed ID: 2471850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of proglumide on rat pancreatic growth.
    Yamaguchi T; Tabata K; Johnson LR
    Am J Physiol; 1985 Aug; 249(2 Pt 1):G294-8. PubMed ID: 2411150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proglumide fails to increase food intake after an ingested preload.
    Schneider LH; Gibbs J; Smith GP
    Peptides; 1986; 7(1):135-40. PubMed ID: 3714531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of CR-1409, a competitive inhibitor of cholecystokinin, on pancreatic exocrine secretion in the conscious rat.
    Miyasaka K; Nakamura R; Funakoshi A; Kitani K
    Tohoku J Exp Med; 1988 Jun; 155(2):165-72. PubMed ID: 3212779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural features of various proglumide-related cholecystokinin receptor antagonists.
    Jensen RT; Zhou ZC; Murphy RB; Jones SW; Setnikar I; Rovati LA; Gardner JD
    Am J Physiol; 1986 Dec; 251(6 Pt 1):G839-46. PubMed ID: 2431626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a new proglumide analogue CR 1392 on pancreatic exocrine secretion in the rat.
    Otsuki M; Fujii M; Nakamura T; Okabayashi Y; Tani S; Fujisawa T; Koide M; Baba S
    Digestion; 1989; 42(2):61-9. PubMed ID: 2475379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antispasmodic activity on the gallbladder of the mouse of CR 1409 (lorglumide) a potent antagonist of peripheral CCK.
    Makovec F; Bani M; Cereda R; Chistè R; Pacini MA; Revel L; Rovati LC
    Pharmacol Res Commun; 1987 Jan; 19(1):41-51. PubMed ID: 3575382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.